These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 28455073

  • 1. Physical stability of l-ascorbic acid amorphous solid dispersions in different polymers: A study of polymer crystallization inhibitor properties.
    Christina B, Taylor LS, Mauer LJ.
    Food Res Int; 2015 Oct; 76(Pt 3):867-877. PubMed ID: 28455073
    [Abstract] [Full Text] [Related]

  • 2. Amorphization of thiamine chloride hydrochloride: A study of the crystallization inhibitor properties of different polymers in thiamine chloride hydrochloride amorphous solid dispersions.
    Arioglu-Tuncil S, Bhardwaj V, Taylor LS, Mauer LJ.
    Food Res Int; 2017 Sep; 99(Pt 1):363-374. PubMed ID: 28784494
    [Abstract] [Full Text] [Related]

  • 3. Mid-infrared spectroscopy as a polymer selection tool for formulating amorphous solid dispersions.
    Wegiel LA, Mauer LJ, Edgar KJ, Taylor LS.
    J Pharm Pharmacol; 2014 Feb; 66(2):244-55. PubMed ID: 24433425
    [Abstract] [Full Text] [Related]

  • 4. Effect of Temperature and Moisture on the Physical Stability of Binary and Ternary Amorphous Solid Dispersions of Celecoxib.
    Xie T, Taylor LS.
    J Pharm Sci; 2017 Jan; 106(1):100-110. PubMed ID: 27476771
    [Abstract] [Full Text] [Related]

  • 5. Crystallization of amorphous solid dispersions of resveratrol during preparation and storage-Impact of different polymers.
    Wegiel LA, Mauer LJ, Edgar KJ, Taylor LS.
    J Pharm Sci; 2013 Jan; 102(1):171-84. PubMed ID: 23132686
    [Abstract] [Full Text] [Related]

  • 6. Evaluate the ability of PVP to inhibit crystallization of amorphous solid dispersions by density functional theory and experimental verify.
    Wang B, Wang D, Zhao S, Huang X, Zhang J, Lv Y, Liu X, Lv G, Ma X.
    Eur J Pharm Sci; 2017 Jan 01; 96():45-52. PubMed ID: 27568852
    [Abstract] [Full Text] [Related]

  • 7. Degradation of L-Ascorbic Acid in the Amorphous Solid State.
    Sanchez JO, Ismail Y, Christina B, Mauer LJ.
    J Food Sci; 2018 Mar 01; 83(3):670-681. PubMed ID: 29405290
    [Abstract] [Full Text] [Related]

  • 8. Effect of temperature and moisture on the miscibility of amorphous dispersions of felodipine and poly(vinyl pyrrolidone).
    Marsac PJ, Rumondor AC, Nivens DE, Kestur US, Stanciu L, Taylor LS.
    J Pharm Sci; 2010 Jan 01; 99(1):169-85. PubMed ID: 19492305
    [Abstract] [Full Text] [Related]

  • 9. Phase behavior of poly(vinylpyrrolidone) containing amorphous solid dispersions in the presence of moisture.
    Rumondor AC, Marsac PJ, Stanford LA, Taylor LS.
    Mol Pharm; 2009 Jan 01; 6(5):1492-505. PubMed ID: 19634917
    [Abstract] [Full Text] [Related]

  • 10. Physical stability of the amorphous state of loperamide and two fragment molecules in solid dispersions with the polymers PVP-K30 and PVP-VA64.
    Weuts I, Kempen D, Decorte A, Verreck G, Peeters J, Brewster M, Van den Mooter G.
    Eur J Pharm Sci; 2005 Jun 01; 25(2-3):313-20. PubMed ID: 15911228
    [Abstract] [Full Text] [Related]

  • 11. Amorphization of Thiamine Mononitrate: A Study of Crystallization Inhibition and Chemical Stability of Thiamine in Thiamine Mononitrate Amorphous Solid Dispersions.
    Arioglu-Tuncil S, Voelker AL, Taylor LS, Mauer LJ.
    Int J Mol Sci; 2020 Dec 09; 21(24):. PubMed ID: 33316991
    [Abstract] [Full Text] [Related]

  • 12. Role of the Strength of Drug-Polymer Interactions on the Molecular Mobility and Crystallization Inhibition in Ketoconazole Solid Dispersions.
    Mistry P, Mohapatra S, Gopinath T, Vogt FG, Suryanarayanan R.
    Mol Pharm; 2015 Sep 08; 12(9):3339-50. PubMed ID: 26070543
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of albendazole crystallization in poly(vinylpyrrolidone) solid molecular dispersions.
    Kalaiselvan R, Mohanta GP, Manna PK, Manavalan R.
    Pharmazie; 2006 Jul 08; 61(7):618-24. PubMed ID: 16889070
    [Abstract] [Full Text] [Related]

  • 14. Investigation into Intermolecular Interactions and Phase Behavior of Binary and Ternary Amorphous Solid Dispersions of Ketoconazole.
    Sarpal K, Tower CW, Munson EJ.
    Mol Pharm; 2020 Mar 02; 17(3):787-801. PubMed ID: 31860316
    [Abstract] [Full Text] [Related]

  • 15. The role of drug-polymer hydrogen bonding interactions on the molecular mobility and physical stability of nifedipine solid dispersions.
    Kothari K, Ragoonanan V, Suryanarayanan R.
    Mol Pharm; 2015 Jan 05; 12(1):162-70. PubMed ID: 25426538
    [Abstract] [Full Text] [Related]

  • 16. Theoretical and experimental investigation of drug-polymer interaction and miscibility and its impact on drug supersaturation in aqueous medium.
    Baghel S, Cathcart H, O'Reilly NJ.
    Eur J Pharm Biopharm; 2016 Oct 05; 107():16-31. PubMed ID: 27378287
    [Abstract] [Full Text] [Related]

  • 17. Colyophilized Sugar-Polymer Dispersions for Enhanced Processing and Storage Stability.
    Giannachi C, Allen E, Egan G, Vucen S, Crean A.
    Mol Pharm; 2024 Jun 03; 21(6):3017-3026. PubMed ID: 38758116
    [Abstract] [Full Text] [Related]

  • 18. Physical properties of solid molecular dispersions of indomethacin with poly(vinylpyrrolidone) and poly(vinylpyrrolidone-co-vinyl-acetate) in relation to indomethacin crystallization.
    Matsumoto T, Zografi G.
    Pharm Res; 1999 Nov 03; 16(11):1722-8. PubMed ID: 10571278
    [Abstract] [Full Text] [Related]

  • 19. Physicochemical characterization of hot melt extruded bicalutamide-polyvinylpyrrolidone solid dispersions.
    Andrews GP, AbuDiak OA, Jones DS.
    J Pharm Sci; 2010 Mar 03; 99(3):1322-35. PubMed ID: 19798757
    [Abstract] [Full Text] [Related]

  • 20. Ability of different polymers to inhibit the crystallization of amorphous felodipine in the presence of moisture.
    Konno H, Taylor LS.
    Pharm Res; 2008 Apr 03; 25(4):969-78. PubMed ID: 17520180
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.